0,757  0,002  Toll-Like receptor 7 antagonist
0,659  0,004  Systemic lupus erythematosus treatment
0,605  0,007  GABA C receptor rho-3 antagonist
0,564  0,012  Ulceration
0,561  0,017  CYP1A2 substrate
0,544  0,005  Antineoplastic (small cell lung cancer)
0,541  0,016  Multiple sclerosis treatment
0,533  0,019  Immunomodulator
0,509  0,003  Toll-Like receptor antagonist
0,490  0,007  Antineoplastic (bladder cancer)
0,511  0,035  Rheumatoid arthritis treatment
0,505  0,035  CYP2C9 substrate
0,464  0,004  Toll-Like receptor 9 antagonist
0,353  0,003  Toll-Like receptor 3 antagonist
0,366  0,021  Antiparkinsonian, rigidity relieving
0,371  0,029  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,371  0,052  5 Hydroxytryptamine release stimulant
0,371  0,073  Antineoplastic (lung cancer)
0,405  0,108  Caspase 9 stimulant
0,347  0,053  CYP3A4 inhibitor
0,398  0,107  Antineoplastic (solid tumors)
0,300  0,012  DNA intercalator
0,337  0,051  Aryl hydrocarbon receptor agonist
0,340  0,057  Antineoplastic (melanoma)
0,354  0,076  CYP3A4 substrate
0,386  0,114  Autoimmune disorders treatment
0,350  0,081  CYP2C9 inhibitor
0,274  0,008  GABA receptor agonist
0,327  0,072  Antineoplastic (colorectal cancer)
0,281  0,028  Pneumotoxic
0,291  0,039  Gastrin inhibitor
0,302  0,050  Antineoplastic (liver cancer)
0,260  0,010  GABA C receptor rho-2 antagonist
0,342  0,096  CYP2C19 inhibitor
0,317  0,070  Antineoplastic (colon cancer)
0,292  0,046  Antineoplastic (lymphocytic leukemia)
0,248  0,004  Gonadotropin-releasing hormone receptor antagonist
0,255  0,016  Topoisomerase I inhibitor
0,317  0,078  FMO1 substrate
0,274  0,035  UGT1A4 substrate
0,296  0,062  UGT1A9 substrate
0,292  0,060  DNA damaging
0,358  0,142  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,220  0,005  GABA A receptor antagonist
0,218  0,005  GABA receptor antagonist
0,220  0,010  Protein kinase C gamma inhibitor
0,264  0,055  UGT1A6 substrate
0,256  0,047  Sedative
0,235  0,030  Vascular endothelial growth factor 3 antagonist
0,269  0,069  Antineoplastic (non-small cell lung cancer)
0,209  0,009  GABA A receptor agonist
0,248  0,051  Anesthetic general
0,225  0,029  Aldehyde oxidase substrate
0,264  0,071  Antineoplastic (renal cancer)
0,213  0,020  Ferrochelatase inhibitor
0,295  0,102  Antiprotozoal (Plasmodium)
0,200  0,010  Multidrug resistance-associated protein 1 inhibitor
0,272  0,083  FMO3 substrate
0,201  0,014  Telomerase inhibitor
0,197  0,014  Antineoplastic alkaloid
0,219  0,037  Antiparkinsonian, tremor relieving
0,184  0,003  Toll-Like receptor 8 antagonist
0,302  0,122  Histamine release inhibitor
0,193  0,014  GABA C receptor antagonist
0,190  0,013  Protein kinase C zeta inhibitor
0,257  0,082  CYP1A2 inhibitor
0,248  0,080  Interleukin agonist
0,235  0,068  Antiparasitic
0,234  0,070  MAP-kinase-activated kinase 5 inhibitor
0,167  0,006  Protein kinase C eta inhibitor
0,170  0,010  Cyclin B3 inhibitor
0,251  0,091  CYP2C19 substrate
0,178  0,019  Photosensitizer
0,184  0,025  Antiprotozoal (Amoeba)
0,217  0,068  Ca2+/calmodulin-dependent protein kinase inhibitor
0,202  0,053  VEGF expression inhibitor
0,233  0,087  Vascular (periferal) disease treatment
0,170  0,025  Fibroblast growth factor 1 antagonist
0,199  0,055  Prostatic (benign) hyperplasia treatment
0,235  0,093  Flavin-containing monooxygenase substrate
0,208  0,070  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,210  0,075  MAP kinase kinase 2 inhibitor
0,162  0,030  Butyrylcholinesterase inhibitor
0,148  0,017  5 Hydroxytryptamine 1F antagonist
0,142  0,012  Glutamate release inhibitor
0,232  0,104  UGT2B4 substrate
0,173  0,045  Antiseptic
0,138  0,010  Glycine receptor antagonist
0,176  0,049  CNS active muscle relaxant
0,149  0,022  GABA C receptor rho-1 antagonist
0,156  0,030  Antiprotozoal (Babesia)
0,160  0,037  Pregnane X receptor agonist
0,167  0,046  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,175  0,055  UGT2B9 substrate
0,143  0,025  Prolactin inhibitor
0,237  0,119  GST M1-1 substrate
0,189  0,072  Mutagenic
0,152  0,035  MAP kinase 13 inhibitor
0,210  0,094  Antineoplastic (glioma)
0,161  0,044  Topoisomerase II inhibitor
0,149  0,033  Alpha 2c adrenoreceptor antagonist
0,222  0,109  Chemoprotective
0,152  0,041  MAP kinase 12 inhibitor
0,114  0,005  Cyclin D1 inhibitor
0,146  0,037  SULT1A1 substrate
0,128  0,018  Bromodomain-containing protein 2 inhibitor
0,122  0,015  Protein kinase C alpha inhibitor
0,173  0,067  ATPase inhibitor
0,215  0,110  Tyrosine 3 hydroxylase inhibitor
0,198  0,095  Antineoplastic (lymphoma)
0,120  0,016  Benzodiazepine agonist
0,241  0,138  Sodium/bile acid cotransporter inhibitor
0,224  0,122  CYP2D6 substrate
0,158  0,057  SULT1A3 substrate
0,222  0,124  Antihypoxic
0,218  0,120  5 Hydroxytryptamine uptake stimulant
0,139  0,043  Polo-like kinase-4 inhibitor
0,139  0,044  Alpha 2b adrenoreceptor antagonist
0,198  0,103  Antineoplastic (cervical cancer)
0,166  0,071  UGT1A3 substrate
0,139  0,045  Vascular endothelial growth factor 1 antagonist
0,113  0,020  Interferon agonist
0,209  0,116  Antineoplastic (ovarian cancer)
0,186  0,093  Antineoplastic (glioblastoma multiforme)
0,160  0,068  Carcinogenic, group 1
0,104  0,012  Antidote, organophosphates
0,151  0,059  Cyclin-dependent kinase 7 inhibitor
0,198  0,110  Antipyretic
0,101  0,013  Protein kinase C beta inhibitor
0,162  0,074  Antiviral (Hepatitis C)
0,250  0,163  Antiprotozoal
0,131  0,047  TRPA1 agonist
0,200  0,117  Antiviral (West Nile virus)
0,242  0,161  Antineoplastic (endocrine cancer)
0,173  0,094  UGT1A1 substrate
0,092  0,016  Interferon inducer
0,176  0,103  Neurotrophic factor enhancer
0,162  0,089  Lipocortins synthesis antagonist
0,160  0,088  LIM domain kinase 1 inhibitor
0,163  0,095  Antihelmintic
0,102  0,034  Hematopoietic
0,073  0,006  Benzodiazepine antagonist
0,097  0,031  Purinergic P2X2 antagonist
0,167  0,102  I kappa B kinase epsilon inhibitor
0,217  0,151  Angiogenesis inhibitor
0,076  0,011  Potassium channel small-conductance Ca-activated blocker
0,198  0,133  Respiratory analeptic
0,083  0,018  Antihemophilic
0,180  0,116  Aldehyde oxidase inhibitor
0,207  0,144  Hypoxia-inducible factor 1 alpha inhibitor
0,087  0,025  MAP kinase 7 inhibitor
0,082  0,020  Cyclin B1 inhibitor
0,238  0,177  Antipruritic, allergic
0,109  0,050  Protein kinase C mu inhibitor
0,176  0,117  5 Hydroxytryptamine 3E antagonist
0,064  0,005  Growth hormone releasing factor antagonist
0,134  0,075  Cytokine production inhibitor
0,175  0,117  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,078  0,020  Potassium channel (Ca-activated) blocker
0,062  0,005  Retinoid X receptor antagonist
0,183  0,127  RNA-directed DNA polymerase inhibitor
0,162  0,106  Pyruvate kinase inhibitor
0,112  0,057  NAT2 substrate
0,112  0,058  Interleukin 2 antagonist
0,137  0,084  Ca2+-transporting ATPase inhibitor
0,192  0,139  Antineoplastic (sarcoma)
0,093  0,041  NAD(P)H dehydrogenase (quinone) inhibitor
0,074  0,023  Fibroblast growth factor 4 antagonist
0,077  0,027  Bombesin 1 receptor agonist
0,116  0,066  Interleukin 8 antagonist
0,055  0,005  Retinoid X alpha receptor antagonist
0,071  0,021  Cyclin B2 inhibitor
0,184  0,135  Antiprotozoal (Trypanosoma)
0,089  0,040  Transforming growth factor beta 3 antagonist
0,069  0,020  5 Hydroxytryptamine 7 agonist
0,120  0,071  Contraceptive female
0,092  0,045  Topoisomerase II alpha inhibitor
0,100  0,053  Protein kinase C delta inhibitor
0,120  0,073  DNA repair enzyme inhibitor
0,057  0,010  Alpha 1L adrenoreceptor agonist
0,127  0,081  Sphingosine 1-phosphate receptor 2 antagonist
0,192  0,146  Anxiolytic
0,122  0,076  Acetylcholinesterase inhibitor
0,068  0,023  Cyclin B inhibitor
0,149  0,105  Neurotensin receptor agonist
0,186  0,143  Analeptic
0,076  0,033  Glutamate (mGluR7) antagonist
0,083  0,041  SULT1A2 substrate
0,068  0,025  Protein kinase C epsilon inhibitor
0,076  0,035  5 Hydroxytryptamine 3A antagonist
0,070  0,028  Corticotropin releasing factor 2 receptor antagonist
0,094  0,053  Actinic keratosis treatment
0,252  0,212  Apoptosis agonist
0,140  0,100  Uterine stimulant
0,152  0,112  Antiviral (Hepatitis)
0,123  0,083  Antiprotozoal (Trichomonas)
0,136  0,098  UGT2B7 substrate
0,052  0,014  AMPA 4 receptor antagonist
0,107  0,069  Endometrios treatment
0,084  0,046  Alpha 2a adrenoreceptor antagonist
0,108  0,070  Acetylcholine release stimulant
0,066  0,029  Phosphodiesterase 1A inhibitor
0,090  0,054  Tocolytic
0,126  0,090  Acaricide
0,043  0,008  Kainate receptor 4 antagonist
0,143  0,110  Cytotoxic
0,131  0,097  Antifungal (Cryptococcus)
0,078  0,046  Ankylosing spondylitis treatment
0,088  0,056  Antileprosy
0,064  0,033  5 Hydroxytryptamine 6 antagonist
0,088  0,057  Histamine N-methyltransferase inhibitor
0,050  0,019  GABA B receptor antagonist
0,143  0,112  DNA methyltransferase I inhibitor
0,089  0,059  Phosphodiesterase I inhibitor
0,084  0,054  Estrogen-related receptor beta agonist
0,070  0,041  5 Hydroxytryptamine 1B antagonist
0,109  0,080  Shock treatment
0,154  0,126  CYP2B6 inhibitor
0,134  0,107  Mcl-1 antagonist
0,041  0,013  Benzodiazepine receptor peripheral-type antagonist
0,195  0,168  Antileukemic
0,082  0,056  Caspase 7 inhibitor
0,067  0,041  5 Hydroxytryptamine 1D antagonist
0,074  0,048  Glycine receptor agonist
0,043  0,018  5 Hydroxytryptamine 3B antagonist
0,067  0,043  Uterine relaxant
0,145  0,123  Antineoplastic (bone cancer)
0,132  0,110  Heat shock protein 70 antagonist
0,156  0,135  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,059  0,037  5 Hydroxytryptamine 3 antagonist
0,118  0,097  Neurotrophic factor
0,174  0,153  Antituberculosic
0,173  0,152  Superoxide dismutase inhibitor
0,059  0,038  Protein kinase C theta inhibitor
0,063  0,042  Phosphodiesterase 1C inhibitor
0,159  0,138  Antineoplastic enhancer
0,047  0,027  NMDA receptor subunit 3B antagonist
0,069  0,049  Prostaglandin-E synthase inhibitor
0,125  0,106  Thiol protease inhibitor
0,128  0,109  Antinephritic
0,085  0,066  Pim-3 kinase inhibitor
0,163  0,144  Antiviral (Ebola)
0,037  0,018  HMG CoA reductase inhibitor
0,196  0,177  Ca2+/calmodulin-dependent kinase IV inhibitor
0,030  0,012  Toll-Like receptor 4 agonist
0,136  0,118  Amyloid beta precursor protein antagonist
0,100  0,083  5 Hydroxytryptamine 2B antagonist
0,117  0,100  UGT2B15 substrate
0,061  0,044  5 Hydroxytryptamine 5A antagonist
0,034  0,018  Estrogen-related receptor beta antagonist
0,142  0,127  Non-steroidal antiinflammatory agent
0,114  0,100  Protein kinase C nu inhibitor
0,059  0,045  TRPA1 antagonist
0,121  0,107  Src kinase inhibitor
0,169  0,155  Radioprotector
0,062  0,049  Aryl hydrocarbon receptor antagonist
0,023  0,010  Retinoid X beta receptor antagonist
0,048  0,035  Cytokine production stimulant
0,051  0,039  Acetyl-CoA transferase inhibitor
0,124  0,112  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,050  0,038  5 Hydroxytryptamine 4 antagonist
0,084  0,072  Paget's disease treatment
0,038  0,027  Antiviral (Bovine viral diarrhea virus)
0,176  0,165  Prostate cancer treatment
0,046  0,035  AMPA receptor antagonist
0,127  0,116  Heat shock protein 90 alpha antagonist
0,138  0,128  UGT2B10 substrate
0,087  0,077  Cyclin-dependent kinase 1 inhibitor
0,030  0,020  AMPA 2 receptor antagonist
0,050  0,041  5 Hydroxytryptamine 1B agonist
0,076  0,067  Carcinogenic, group 2A
0,119  0,111  Skeletal muscle relaxant
0,114  0,106  Nav1.6 sodium channel blocker
0,027  0,019  Retinoid X gamma receptor antagonist
0,039  0,031  Acetyl-CoA transferase 1 inhibitor
0,056  0,048  Phosphodiesterase 1B inhibitor
0,021  0,014  Kainate receptor 5 antagonist
0,046  0,040  Bromodomain-containing protein 3 inhibitor
0,010  0,005  Corticotropin releasing factor antagonist
0,053  0,049  5 Hydroxytryptamine 5 antagonist
0,017  0,013  Kainate receptor 3 antagonist
0,184  0,180  Cholesterol antagonist
0,126  0,123  Prostate disorders treatment
0,119  0,117  Antidiarrheal
0,026  0,023  Cyclin E2 inhibitor
0,026  0,023  Melatonin antagonist
0,069  0,067  Fibroblast growth factor 3 antagonist
0,135  0,132  DNA methylase inhibitor
0,038  0,036  Antiprotozoal (Histomonas)
0,141  0,139  EphB2 antagonist
0,054  0,052  Cyclin A1 inhibitor
0,086  0,084  Sulfotransferase substrate
0,043  0,042  Benzodiazepine inverse agonist
0,044  0,043  Topoisomerase II beta inhibitor
0,075  0,074  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,017  0,016  Melatonin 1 antagonist
0,013  0,013  Calcium-sensing receptor antagonist
0,015  0,015  Thyroid hormone alpha agonist

